It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Sarcopenia is a progressive loss of muscle mass and strength that is associated with increasing the risk of falls, musculoskeletal diseases, and chronic metabolic diseases. However, the animal models adopted to study sarcopenia face limitations since the functional tests conducted on human cannot be directly adapted to animals because the animals do not follow instructions. Moreover, current preclinical research tools for muscle function assessment, such as the rotarod, grip strength, and treadmill, have limitations, including low-intensity simple movements, evaluator subjectivity, and limited power indicators. Hence, in this study, we present a new jumping-power assessment tool in a preclinical rodent model to demonstrate muscle functions. To overcome the light weight and command issues in the rodent model, we developed an electrical stimulation-assisted jump power assessment device. Precisely, the device utilizes a load cell with a 0.1 g resolution and a 50 points/s data acquisition rate to capture the short period of the mouse jump. Additionally, interdigitated electrodes are used to electrically stimulate the mice and make them jump. While our primary focus in this article is the validation of the newly developed jump power assessment device, it is worth noting that this tool has several potential utilities. These include the phenotypic comparison of sarcopenia models, the exploration of muscle function reduction mechanisms, muscle function-related blood biomarkers, and the evaluation of drug intervention effects.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Yonsei University, Department of Materials Science and Engineering, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
2 Yonsei University Health System, Seoul, Korea (GRID:grid.413046.4) (ISNI:0000 0004 0439 4086)
3 Yonsei University College of Medicine, Department of Integrative Medicine, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454); Severance Hospital, Institue for Innovation in Digital Healthcare (IIDH), Seoul, Korea (GRID:grid.415562.1) (ISNI:0000 0004 0636 3064)
4 Severance Hospital, Institue for Innovation in Digital Healthcare (IIDH), Seoul, Korea (GRID:grid.415562.1) (ISNI:0000 0004 0636 3064); Yonsei University College of Medicine, Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)
5 Yonsei University College of Medicine, Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Seoul, Korea (GRID:grid.15444.30) (ISNI:0000 0004 0470 5454)